Stent
Payments companies reported to CMS as associated with Stent. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Stent, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Stent
These are the largest totals companies reported as associated with Stent. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Oded Goren | Danville, PA | Neurological Surgery | $90,515.12 |
| Yi Zhang | Honolulu, HI | Neurological Surgery | $69,626.28 |
| Orlando Diaz | Houston, TX | Vascular & Interventional Radiology | $60,773.90 |
| Alexander Copelan | Eden Prairie, MN | Neuroradiology | $47,041.11 |
| Jeremy Heit | Stanford, CA | Diagnostic Neuroimaging (Radiology) | $38,874.09 |
| Ferdinand Hui | Honolulu, HI | Diagnostic Radiology | $35,724.00 |
| Edgar Samaniego | Iowa City, IA | Vascular & Interventional Radiology | $33,759.10 |
| Samuel Tsappidi | Augusta, GA | Neurocritical Care | $33,357.88 |
| Bharathi Jagadeesan | Minneapolis, MN | Diagnostic Radiology | $30,926.73 |
| John Chaloupka | Miami Beach, FL | Vascular & Interventional Radiology | $26,647.00 |
Prescribed Stent?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.